Physorg (Free subscription) | 19/11/2009
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Science Daily (Free subscription) | 19/11/2009
The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus 'shell' used to transmit the therapy around the body, according to new research. The researchers behind the study say their findings mean scientists may have to rethink other vaccines they are developing for diseases like HIV, tuberculosis and malaria, which are delivered in the same way, using the same...
Eurekalert (Free subscription) | 19/11/2009
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Medical News Today (Free subscription) | 18/11/2009
Global Corruption Fight Slowing, Report Says A new report from Transparency International says the fight against corruption worldwide is slowing as urgency to address the global economic downturn recedes, Bloomberg reports.
Medical News Today (Free subscription) | 17/11/2009
The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus 'shell' used to transmit the therapy around the body, according to research published 16 November 2009 in the Proceedings of the National Academy of Sciences.
Red Orbit (Free subscription) | 16/11/2009
The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus 'shell' used to transmit the therapy around the body, according to research published today (16 November 2009) in the Proceedings of the National Academy of Sciences.The trial, called 'STEP', was halted in September 2007 because preliminary results suggested that people who had been given the vaccine...
MSNBC.com (Free subscription) | 16/11/2009
The failure of an experimental AIDS vaccine trial two years ago may have been caused by the common cold virus. The test was canceled after volunteers who got the shots were more likely to become infected than those who got a dummy shot. Common cold - HIV vaccine - Virus - Health - AIDS
New Scientist (Free subscription) | 16/11/2009
Cold virus used in vaccine may raise HIV infection risk after all
Kevin, M.D. - Medical Weblog (Free subscription) | 16/11/2009
Originally published in MedPage Today by Peggy Peck, MedPage Today Executive Editor Boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis in high-risk patients on long-term statin therapy than seeking additional LDL cholesterol reductions by adding ezetimibe (Zetia), researchers here reported. Compared with ezetimibe, 2 grams of niacin led...
Eurekalert (Free subscription) | 16/11/2009
The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus 'shell' used to transmit the therapy around the body, according to research published today (November 16, 2009) in the Proceedings of the National Academy of Sciences. The researchers behind the study say their findings mean scientists may have to rethink other vaccines they are developing for diseases...
The Business Insider (Free subscription) | 12/11/2009
Ending the worldwide AIDS epidemic would be awesome, but have you seen the demos of Microsoft's controller-free gaming system? Time Magazine released its list of the 50 best inventions of 2009 . The AIDS vaccine was good for 8th place, behind the tank-bred tuna (#2), the "smart thermostat" (#4), and, yes, Project Natal (#5). The top spot went to NASA's Ares 1 rocket, which could take man...
The AIDS Pandemic (Free subscription) | 11/11/2009
I'm Paige Bates and this is The AIDS Pandemic The RV144 study was a phase III HIV vaccine trial conducted by the US Army and Thai government over seven years on 16,402 volunteers—all HIV negative men and women between the ages of 18 and 30 in parts of Thailand. For ethical reasons, all participants were taught HIV prevention behaviors, given condoms, and promised lifelong antiretroviral treatment...
Science - The Post Chronicle (Free subscription) | 11/11/2009
U.S. scientists seeking a vaccine for the human immunodeficiency virus say a study of HIV antibodies is leading them in a new direction....
Fight HIV in DC (Free subscription) | 09/11/2009
Free World AIDS Day Luncheon HIV Vaccine Research: A New Chapter December 1st, 2009 12:00 Noon to 2:00 PM HRC Equality Center, 1640 Rhode Island Ave, NW Scientists have been searching for a vaccine to prevent HIV infection since the virus was first identified in 1983. Each clinical trial brings us one step closer to finding an effective vaccine. More than 25,000 HIV-negative individuals have participated...
Red Orbit (Free subscription) | 05/11/2009
MIT economist Jeffrey Harris argues that while the scientific obstacles to creating an HIV vaccine are great, the lack of commercial incentive poses a major problem.
Videos